Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Sanofi, GSK to start potential COVID-19 vaccine trial
Sanofi, GSK to start potential COVID-19 vaccine trial
Paris-based pharmaceutical company Sanofi and pharma giant GSK announced Thursday they are starting clinical trials of their COVID-19 vaccine.
WHO updates clinical care guidance with corticosteroid recommendations
WHO updates clinical care guidance with corticosteroid recommendations
On 2 September, WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
Oxford, UK – 1 September, 2020.
Jubilant Life Sciences seeks nod to roll out Remdesivir tablet
Jubilant Life Sciences seeks nod to roll out Remdesivir tablet
NEW DELHI.
Honeybee venom compound shown to kill aggressive breast cancer cells: Aussie research
Honeybee venom compound shown to kill aggressive breast cancer cells: Aussie research
SYDNEY, Sept.
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
FOSTER CITY, Calif.
AZ' Imfinzi bags new approval for lung cancer
AZ' Imfinzi bags new approval for lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination...
FDA willing to fast track coronavirus vaccine before phase three trials end
FDA willing to fast track coronavirus vaccine before phase three trials end
The chief of the Food and Drug Administration is prepared to bypass the full federal approval process in order to make a Covid-19 vaccine available as soon as possible, according to an interview in th...
Nestlé to acquire Aimmune Therapeutics
Nestlé to acquire Aimmune Therapeutics
Nestlé and Aimmune Therapeutics, Inc.
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
PARIS – September 1, 2020 – Sanofi today announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely o...
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment
Vir Biotechnology, Inc.
US approves Roche's new pan-tumour liquid biopsy test
US approves Roche's new pan-tumour liquid biopsy test
US regulators have approved Roche's new pan-tumour liquid biopsy test for patients with solid tumours, offering a potentially more convenient option and an alternative for patients unable to have ...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand